Loading clinical trials...
Loading clinical trials...
A Randomized, Multiple Dose, Placebo and Active Controlled 3-way Crossover Study to Investigate the Effects of Esreboxetine on QTc Interval in Healthy Volunteers
Conditions
Interventions
esreboxetine
placebo
+1 more
Locations
1
Belgium
Pfizer Investigational Site
Brussels, Belgium
Start Date
December 1, 2008
Primary Completion Date
July 1, 2009
Completion Date
July 1, 2009
Last Updated
April 7, 2011
NCT05901259
NCT03759522
NCT07186751
NCT06574165
NCT06157866
NCT05067998
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions